Market Overview:
The global pain relief patches market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and technological advancements in the field of pain management. The global pain relief patches market is segmented on the basis of type, application, and region. On the basis of type, it is divided into lidocaine patches, diclofenac patches, indomethacin patches, counter-irritant patches fentanyl Patches , and other types. Lidocaine Patches are expected to dominate this market owing to their high efficacy in relieving various types of pains such as neuropathic pain and musculoskeletal pain . On the basis o f application , th e over-the-counter (OTC) segment dominates this market followed by prescription drugs . OTC products are available without any prescription while prescription drugs need a doctor’s recommendation for use .
Product Definition:
A pain relief patch is a type of adhesive bandage that is applied to the skin in order to relieve pain. These patches can be used to treat a variety of conditions, such as headache, muscle ache, toothache, and menstrual cramps. They work by releasing medication directly into the affected area. Pain relief patches are an effective way to treat pain without having to take medication orally.
Lidocaine Patches:
Lidocaine patches are transdermal drug delivery systems containing the active ingredient lidocaine that is used for the treatment of pain. The system works by allowing rapid absorption of lidocaine through the skin and providing continuous or intermittent analgesia as per requirement.
The product has been studied extensively for its use in post-operative pain management, where it was found to be as effective as conventional opiate drugs in reducing acute post-operative pain however with fewer side effects.
Diclofenac Patches:
Diclofenac patches are transdermal patches that release the drug diclofenac into the skin. Diclofenac is an anti-inflammatory drug used to reduce pain and inflammation. The medication is available in various forms such as gels, creams, tablets, and films but these topical patches are commonly prescribed by doctors due to their ease of application and long term use.
Application Insights:
The over-the-counter (OTC) application segment dominated the global pain relief patches market in 2017. The OTC application of pain patches is expected to witness significant growth due to increasing usage of these products for acute as well as chronic pains. Increasing use of heat and cold therapy products for pain management, growing preference for home treatment over medical treatment, and rising cases of chronic pains are some factors that are likely to propel the demand in the OTC segment.
Rx applications accounted for a revenue share of 41% in 2017 owing to high adoption rates by healthcare professionals across various regions including North America, Europe, Asia Pacific, Latin America etc. Growing awareness about better treatments options with more effective results coupled with technological advancements is anticipated to boost product demand under prescription during the forecast period.
Furthermore, new product launches coupled with an increase in healthcare spending by governments across various countries such as China India etc.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large patient pool and well-established healthcare infrastructure. Moreover, increasing prevalence of chronic pain conditions such as arthritis, back pain, and cancer is expected to drive regional growth over the forecast period. According to NCBI, approximately 2 million people in U.S. were diagnosed with cancer during 2016; this number is estimated to reach 2.7 million by 2020 accounting for about 11% increase annually over four years duration (NCBI).
In Asia Pacific region lidocaine patches accounted for maximum share followed by diclofenac patches due their rapid penetration across various markets including China and Japan along with other emerging countries such as India and Indonesia (OTC).
Growth Factors:
- Increasing geriatric population: The global population of people aged 60 years and above is expected to exceed 1 billion by 2030. This growing segment is more susceptible to chronic pain, which can be treated with pain relief patches.
- Rising awareness about the benefits of pain relief patches: There has been a rise in the awareness about the benefits of using pain relief patches, such as ease of use and no side effects. This is driving demand for these products.
- Technological advancements: The development of new technologies has led to the introduction of innovative and advanced pain relief patches that are more effective in providing relief from chronic pain symptoms. This is contributing to market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pain Relief Patches Market Research Report
By Type
Lidocaine Patches, Diclofenac Patches, Indomethacin Patches, Counter-Irritant Patches, Fentanyl Patches, Other
By Application
OTC, Rx
By Companies
Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Mentholatum Company, Laboratoires Genevrier, BLUE-EMU
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Pain Relief Patches Market Report Segments:
The global Pain Relief Patches market is segmented on the basis of:
Types
Lidocaine Patches, Diclofenac Patches, Indomethacin Patches, Counter-Irritant Patches, Fentanyl Patches, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
OTC, Rx
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hisamitsu
- Mylan
- Johnson & Johnson
- Actavis
- Lingrui
- Teikoku Seiyaku
- Sanofi
- Novartis
- Qizheng
- Endo
- Huarun 999
- GSK
- Haw Par
- Nichiban
- Mentholatum Company
- Laboratoires Genevrier
- BLUE-EMU
Highlights of The Pain Relief Patches Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lidocaine Patches
- Diclofenac Patches
- Indomethacin Patches
- Counter-Irritant Patches
- Fentanyl Patches
- Other
- By Application:
- OTC
- Rx
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pain Relief Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pain relief patches are adhesive bandages that are designed to provide short-term pain relief. They come in a variety of shapes and sizes, and can be worn on the skin or applied to clothing.
Some of the major players in the pain relief patches market are Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Mentholatum Company, Laboratoires Genevrier, BLUE-EMU.
The pain relief patches market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pain Relief Patches Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pain Relief Patches Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pain Relief Patches Market - Supply Chain
4.5. Global Pain Relief Patches Market Forecast
4.5.1. Pain Relief Patches Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pain Relief Patches Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pain Relief Patches Market Absolute $ Opportunity
5. Global Pain Relief Patches Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pain Relief Patches Market Size and Volume Forecast by Type
5.3.1. Lidocaine Patches
5.3.2. Diclofenac Patches
5.3.3. Indomethacin Patches
5.3.4. Counter-Irritant Patches
5.3.5. Fentanyl Patches
5.3.6. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pain Relief Patches Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pain Relief Patches Market Size and Volume Forecast by Application
6.3.1. OTC
6.3.2. Rx
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pain Relief Patches Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pain Relief Patches Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pain Relief Patches Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pain Relief Patches Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pain Relief Patches Demand Share Forecast, 2019-2026
9. North America Pain Relief Patches Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pain Relief Patches Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pain Relief Patches Market Size and Volume Forecast by Application
9.4.1. OTC
9.4.2. Rx
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pain Relief Patches Market Size and Volume Forecast by Type
9.7.1. Lidocaine Patches
9.7.2. Diclofenac Patches
9.7.3. Indomethacin Patches
9.7.4. Counter-Irritant Patches
9.7.5. Fentanyl Patches
9.7.6. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pain Relief Patches Demand Share Forecast, 2019-2026
10. Latin America Pain Relief Patches Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pain Relief Patches Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pain Relief Patches Market Size and Volume Forecast by Application
10.4.1. OTC
10.4.2. Rx
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pain Relief Patches Market Size and Volume Forecast by Type
10.7.1. Lidocaine Patches
10.7.2. Diclofenac Patches
10.7.3. Indomethacin Patches
10.7.4. Counter-Irritant Patches
10.7.5. Fentanyl Patches
10.7.6. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pain Relief Patches Demand Share Forecast, 2019-2026
11. Europe Pain Relief Patches Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pain Relief Patches Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pain Relief Patches Market Size and Volume Forecast by Application
11.4.1. OTC
11.4.2. Rx
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pain Relief Patches Market Size and Volume Forecast by Type
11.7.1. Lidocaine Patches
11.7.2. Diclofenac Patches
11.7.3. Indomethacin Patches
11.7.4. Counter-Irritant Patches
11.7.5. Fentanyl Patches
11.7.6. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pain Relief Patches Demand Share, 2019-2026
12. Asia Pacific Pain Relief Patches Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pain Relief Patches Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pain Relief Patches Market Size and Volume Forecast by Application
12.4.1. OTC
12.4.2. Rx
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pain Relief Patches Market Size and Volume Forecast by Type
12.7.1. Lidocaine Patches
12.7.2. Diclofenac Patches
12.7.3. Indomethacin Patches
12.7.4. Counter-Irritant Patches
12.7.5. Fentanyl Patches
12.7.6. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pain Relief Patches Demand Share, 2019-2026
13. Middle East & Africa Pain Relief Patches Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pain Relief Patches Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pain Relief Patches Market Size and Volume Forecast by Application
13.4.1. OTC
13.4.2. Rx
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pain Relief Patches Market Size and Volume Forecast by Type
13.7.1. Lidocaine Patches
13.7.2. Diclofenac Patches
13.7.3. Indomethacin Patches
13.7.4. Counter-Irritant Patches
13.7.5. Fentanyl Patches
13.7.6. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pain Relief Patches Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pain Relief Patches Market: Market Share Analysis
14.2. Pain Relief Patches Distributors and Customers
14.3. Pain Relief Patches Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hisamitsu
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mylan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson & Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Actavis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lingrui
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teikoku Seiyaku
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Novartis
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Qizheng
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Endo
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Huarun 999
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GSK
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Haw Par
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Nichiban
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Mentholatum Company
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Laboratoires Genevrier
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. BLUE-EMU
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
